Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
69 Leser
Artikel bewerten:
(0)

China Vitamin Industry 2014 Review of Hot Spots

DALLAS, February 8, 2015 /PRNewswire/ --

MarketReportsOnline.com adds "Annual Review of Hot Spots in China's Vitamin Industry in 2014 Edition (1)" report that exhaustively analyzes vitamin industry background, company dynamics and market price changes of vitamins in China.

In the next few years, the vitamin industry in China will continue to be promising. On the whole, it's worth investing in it. Vitamin industry's major hot topics of 2014 discussed in this research include the following:

On 19 March, 2014, BASF released a statement, explaining that its citral production line in Germany plant had suffered a fire and had to close down. BASF's total citral capacity accounts for more than 60% of the global capacity, thus the fire led to a tight supply of citral and had a huge impact on the downstream of vitamin A, fragrance and flavor, vitamin E and other products. However, even though BASF's citral resumed production as soon as in April 2014, the domestic supply situation didn't change quickly.

On 11 July, 2014, DSM announced that it had reached an agreement to acquire Aland Nutraceutical, a leading producer of vitamin C in China. Through the acquisition, DSM will be able to further strengthen its status in the vitamin C market and spread its domains all over the world in human nutrition and health care, animal nutrition and health care, and personal care.

Complete report available @http://www.marketreportsonline.com/397849.html.

On 25 Oct. 2014, Shandong Haineng Bioengineering Co., Ltd. conducted a "25-hydroxyvitamin D3" press conference in International Conference Center of Jinan City, Shandong Province. Haineng Bioengineering's launching 25-hydroxyvitamin D3 means that China is expected to break monopoly on technology and market dominated by foreign countries to some extent. And it speeds up the production and efficiency of livestock and poultry breeding.

In this report, hot spots in China's vitamin industry in 2014 have been analyzed exhaustively from the following aspects:

  • Background;
  • Company dynamics;
  • Market prices change of vitamins.

Purchase a copy of this report @http://www.marketreportsonline.com/contacts/purchase.php?name=397849.

Major points from Table of Contents:

1 Summary

2 Market Price of Folic Acid Has Maintained Upward Trend Since Jan. 2014

3 Fire Happened in Germany Plant of BASF

4 Garden Biochemical Suspended Production of Cholesterol

5 DSM Acquired Aland Nutraceutical

6 Xinfu Pharmaceutical Combined Two Subsidiaries

7 25-Hydroxyvitamin D3 Launched by Haineng Bioengineering

8 New Production Line of VB3 in Nansha Lonza Launched

Related Report on Vitamin Industry:

Global Vitamin and Provitamin Market to 2018 - Market Size, Trends, and Forecasts (http://www.marketreportsonline.com/328484.html) this industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for vitamins and provitamins in the world. The research includes historic market data from 2007 to 2013 and forecasts until 2018.

The product segments analyzed in this data report include: Vitamin A, Vitamin B1, Vitamin B1, Vitamin B12, Vitamin B2, Vitamin B3 and B5, Vitamin B6, Vitamin C, Vitamin E & Other vitamins and provitamins

Key reasons to buy:

  • Gain an outlook of the historic development, current market situation, trends, and future outlook of the vitamin and provitamin market in the world to 2018
  • Track industry trends and identify market opportunities
  • Plan and develop marketing, market-entry, market expansion, and other business strategies by identifying the key market trends and prospects

Explore more reports on Pharmaceuticals Market:

Global In-Vitro Diagnostics (IVD) Market Report: 2014 Edition (http://www.marketreportsonline.com/396473.html) An in-vitro diagnostic test is performed outside of a human body in an artificial environment (e.g. laboratory). IVD is considered as an essential part of today's healthcare. The IVD products are broadly divided into three categories: reagents, analytical instruments and accessory products.

US Pharmacy Benefit Management (PBM) Industry Report: 2014 Edition (http://www.marketreportsonline.com/395328.html) The PBM providers control drug spending and utilization by virtue of their advanced tools and techniques, encouraging use of generics and other lower-cost medications. In the US, there are some independent PBM's while some are owned by managed care organizations and retail pharmacies.

About Us:

MarketReportsOnline.com comprises of an online library of 500,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact:
Ritesh Tiwari
Corporate Office
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com


© 2015 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.